Literature DB >> 14531923

Severe acute respiratory syndrome and lupus anticoagulants in children.

Eudora Y Chow, Wa K Chiu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14531923     DOI： 10.1046/j.1365-2141.2003.04608.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children.

Authors:  C W Leung; W K Chiu
Journal:  Paediatr Respir Rev       Date:  2004-12       Impact factor: 2.726

Review 2.  Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past.

Authors:  Dimitrios Giannis; Ioannis A Ziogas; Panagiota Gianni
Journal:  J Clin Virol       Date:  2020-04-09       Impact factor: 3.168

3.  Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11.

Authors:  Man Cheng; Ceci W L Chan; Randy C F Cheung; Rama Kamesh Bikkavilli; Qi Zhao; Shannon W N Au; Paul K S Chan; Susanna S T Lee; Gregory Cheng; Walter K K Ho; Wing-Tai Cheung
Journal:  Biochem Biophys Res Commun       Date:  2005-10-25       Impact factor: 3.575

Review 4.  COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?

Authors:  Georges El Hasbani; Ali T Taher; Ali Jawad; Imad Uthman
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2020-12-03

Review 5.  Hemostatic system and COVID-19 crosstalk: A review of the available evidence.

Authors:  Mohamed-Naguib Wifi; Mohamed Abdelkader Morad; Reem El Sheemy; Nermeen Abdeen; Shimaa Afify; Mohammad Abdalgaber; Abeer Abdellatef; Mariam Zaghloul; Mohamed Alboraie; Mohamed El-Kassas
Journal:  World J Methodol       Date:  2022-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.